(Total Views: 44)
Posted On: 01/09/2024 10:25:24 AM
Post# of 145174

$XRTX Alliance Global Partners analyst James Molloy maintains XORTX Therapeutics (NASDAQ: XRTX) with a Buy and raises the price target from $9 to $14.
https://www.alsahm.com/news/content/alliance-...2024-01-04
https://www.alsahm.com/news/content/alliance-...2024-01-04

